{"id":"W2798054859","doi":"10.1200/jco.2018.36.4_suppl.560","title":"A phase Ib study of safety and clinical activity of atezolizumab (A) and cobimetinib (C) in patients (pts) with metastatic colorectal cancer (mCRC).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Colorectal cancer; Rash; Clinical endpoint; Atezolizumab; Gastroenterology; Microsatellite instability; Phases of clinical research; Adverse effect; Refractory (planetary science); Oncology; Cancer; Surgery; Chemotherapy; Clinical trial; Nivolumab; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001412186,0.001181524,0.001845258,0.0004906569,0.0004118041,0.0009562306,0.0008654654,0.001146561,0.003862281],"category_scores_gemma":[0.000890236,0.0007075344,0.0009919032,0.0004969297,0.0008890349,0.0008677028,0.0003832416,0.00277834,0.001105384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009921669,"about_ca_system_score_gemma":0.001447267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009914095,"about_ca_topic_score_gemma":0.0021253,"domain_scores_codex":[0.9995896,0.0001791399,0.00002710487,0.00007188864,0.00004034953,0.00009190935],"domain_scores_gemma":[0.9991499,0.0001089722,0.0001574684,0.00006675835,0.00004142694,0.0004754885],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.830184,0.06122411,0.00558729,0.000531728,0.0007598079,0.0002170696,0.0002032736,0.001638017,0.03437286,0.0001992805,0.002044401,0.06303813],"study_design_scores_gemma":[0.5482758,0.4346042,0.01055394,0.0000249238,0.0003727068,0.0002999615,0.00005382826,0.001021529,0.00261466,0.0001266715,0.002029309,0.00002251222],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935122,0.001484218,0.0003883983,0.0002269658,0.00008957838,0.001907077,0.0007791906,0.00005846396,0.001553965],"genre_scores_gemma":[0.9921865,0.001198723,0.001037698,0.0004022408,0.0001305704,0.001986255,0.001542449,0.00001654855,0.00149899],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003862281,"threshold_uncertainty_score":0.01292068,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1027352998852519,"score_gpt":0.5005962849997099,"score_spread":0.3978609851144579,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}